Glycobiology Reagents
Founded on a growing portfolio of purified lectins, lectin conjugates, and lectin screening kits, Vector Laboratories supports the ability to profile, characterize, and capture complex glycans in biological systems.
Receive your quote directly from the manufacturer.
Vector Laboratories’ glycobiology portfolio is built on robust manufacturing and rigorous QC testing that ensure highly sensitive, specific, and reproducible glycan detection. Lectin undergoes validation of binding specificity using NCFG glycan microarray technology, providing researchers with confidence in performance and reliability. Backed by 50 years of experience supplying trusted reagents to the scientific community, Vector Labs continues to deliver products that support accurate discovery and dependable experimental results.
Cutting-edge glycan analysis to transform biopharma and diagnostics
Glycobiology is an expanding field that explores how the diverse process of adding glycans to cellular proteins and lipids (glycosylation) shapes essential biological functions, influences disease progression, and serves as a powerful source of diagnostic biomarkers and therapeutic targets.
With the mammalian glycome comprising thousands of structures, accurate glycan profiling is critical for understanding normal cell activity, cancer biology, biologic drug development, and pathogen behavior, as seen during COVID‑19 when SARS‑CoV‑2 spike protein glycosylation was mapped to reveal mechanisms of host‑cell entry.
Modern lectin-based tools, including Vector Laboratories’ purified lectins, lectin conjugates, screening kits, and the other glycobiology reagents, now enable researchers to sensitively detect, characterize, and spatially map complex glycans across biological systems, driving advances in glycan profiling and the study of altered glycosylation in disease.
Download this SelectScience guide to explore:
- Glycosylation in health and disease states
- The role lectins play
- How to select glycan profiling kits and lectins
- Glycobiology in cancer research as a case study
- Advice from the experts in glycan analysis
Resource details:
- Document type: SelectScience guide
- Page count: 26
- Read time: 39 mins
- Edition: 1st
Vector Laboratories and Spatomics partner to advance high-plex spatial glycan and protein profiling
Vector Laboratories and Spatomics have formed a partnership to advance multiplexed spatial profiling of glycans and proteins. In this SelectScience interview, Rui Zheng, Founder and CEO of Spatomics, explains what spatial biology is and why it is becoming the future of cancer research. He discusses the challenges of spatial assays and how Spatomics’ Cleavable Fluorescent Probe (CFP) technology, combined with Vector Laboratories’ Glysite™ Explorer in situ Glycan Detection Kit, enables highly sensitive, and reproducible spatial detection of glycosylated proteins alongside additional protein markers within the same tissue sample.
This video was filmed at AACR Annual Meeting 2026.
Harvard researchers leverage spatial glycobiology for cancer research
Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies
Spatial glycomics meets proteomics in a new multiplex tissue assay
First-of-its-kind assay by Vector Laboratories and Spatomics enables simultaneous mapping of proteins and glycans on a single slide
